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Abstract Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm, which is derived of mesenchymal origin. Here we present an adult case 
with IMT, the origin of which was considered to be right inferior pulmonary vein. A male patient who was 52 years old, admitted to 
our outpatient clinic with the complaint of shortness of breath. He had cigarette smoking history for 30 years. On direct posterior - 
anterior X-Ray of the chest, a well-circumscribed mass with calcification in right hilum of the lung was observed.  There was a mass 
which was extending to the inferior inferior pulmonary vein from right hilum of the lung, was measured 70 x 60 mm on computed 
tomography of the chest. Hamartoma, teratoma and Castleman Disease were among the possible diagnoses. On diagnostic 
bronchoscopy, signs of pressure from outside to the bronchi of the right middle and lower lobe was observed. Surgical excision is 
decided and the mass was totally excised through a muscle-sparing thoracotomy. The mass thought to arise from the inferior pulmonary 
vein on intraoperative inspection and right inferior lobe excision is undertaken by intrapericardial approach. No postoperative 
complication is encountered. Histological examination of the mass indicated inflammatory myofibroblastic tumor. Main treatment of 
IMT is surgical excision with negative surgical margin. Here in we present an IMT which is encountered at an unexpected location is 
excised completely with right lower lobe excision by an intrapericardial approach.
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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm of mesenchymal origin. As well as being locatedgenerally 
in the lungs of children and adolescents, it can be seen nearly everywhere in the body. Tumors of pulmonary and, more 
rarely, cardiac origin are seen in the adult period. Locally invasive and noninvasive forms have been defined for the 
ones located in the lungs[1]. 
This study aimed to present a case with IMT completely resected by thoracotomy, which was perhaps directly rooted 
from right inferior pulmonary vein (RIPV) and invaded the RIPV macroscopically, and to discuss diagnosis and 
treatment options in cases with IMT located in the thorax.
CASE PRESENTATION
A 52-year-old male patient presented to the chest disease clinic with a complaint of dyspnea. The patient had been 
smoking for thirty years. There was no previous disease in patient’s history. Coarse rales were heard in the right lower 
zone on auscultation. 
A smoothly-marginated lesion showing calcification in the right hilar region was seen on chest radiography (Figure 1A, B). 
A hypodense, smoothly-marginated mass, 70 x 60 mm in size, involving calcification and stretching out to the inferior 
pulmonary vein was seen on computed tomography (Figure 2). Findings of external pressure on mid-right and lower-right 
lobe were detected on bronchoscopy performed for probable diagnoses of hamartoma, teratoma and Castleman disease. 
Biochemical evaluation was as follows: C-Reactive Protein: 7.67 mg/dL, WBC: 10950/mm3, 1 hour erythrocyte 
sedimentation rate: 49, and hemoglobin: 14.2 g/dL. First second force expiration volume (FEV1) of the patient was 1540 
mL (49%), force vital capacity (FVC) was 2510 mL (65%), FEV1/FVC was 61, residual volume was 3280 mL (158%), and 
total lung volume was 6470 mL (106%) in the best respiratory function test of the patient while using a bronchodilator.  
Surgical resection of the tumor was planned and was completely excised with muscle-protecting thoracotomy. It was 
observed during intraoperative evaluation that the tumor was well-marginated; however, while it could be dissected 
* Toraks 18th National Congress, 1-5 April 2015, Belek, Antalya
Turk Thorac J 2016; 17: 128-131
129
from the lung parenchyma with a good margin, it did not 
allow for a dissection in the inferior pulmonary vein region 
(Figure 3A). Hence, intrapericardial right-lower lobectomy 
was performed. There were no postoperative complications. 
Pathologically, a nodular, solid, calcified, brown mass leaning 
against the pulmonary vein, approximately 6.5 x 5 x 5 cm in 
size, was seen in the lung on macroscopic examination 
(Figure 3B). On the external surface of the material, nodular 
protrusions in the visceral pleura covering the lesion drew 
attention. Lung parenchyma was normal in regions without 
the lesion. On the myxoid collagenous bed, a tumoral 
proliferation, with a fusiform nucleus, generated by cells 
showing minimal pleomorphism, which created random 
bundles in some regions, was seen. Plasma cells and 
lymphocytes generating lymphoid follicles in some regions 
were observed on the tumor bed (Figure 4). The number of 
mitoses per 50 high-power fields were two in the microscopic 
examination. While actin was found positive on 
immunohistochemical examination, desmine, p53, HHV-8, 
CD117 and ALK were found negative. CD34 was detected 
positive around vascular regions and in Bcl-2 lymphocytes. 
Ki-67 proliferation index was found as 3%. IMT diagnosis 
was made with these findings. 
There are no recurrent findings in the patient who is in his 
ninth month after resection (Figure 1C).
DISCUSSION
Among the primary pulmonary regions of the adult period, 
IMT is a rarely encountered tumor with a rate of less than 
1%. 44% to 78% of the cases of pulmonary origin are 
symptomatic [1,2,3]. Cough, fever and dyspnea are frequently 
seen signs [1,2,3]. IMT of cardiac origin is mostly in the form 
Figure 1. (A) Pre-operative PA chest radiography of the patient, (B) Pre-operative lateral chest graphy of the patient, (C) Post-operative PA chest 
radiography of the patient.
Figure 2. Thoracic CT sections of the patient. 
Figure 3. (A) Pulmonary vein branch continuing to the lung parenchyma from within the mass, (B) Vein branch progressing into the mass.
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of polypoid lesion with small myocardial infiltrations [4]. 
There is no specific symptom and it can show signs according 
to the location site [5]. IMT associated withheart valves and 
coronary arteries can progress fatally [4]. 
Radiologic findings also vary just as the symptoms. According 
to Argons et al., IMT is generally seen in the lower lobes as a 
solitary, peripheral mass with sharp margins, and invasion, 
mediastinum involvement and invasion of the hilar structures 
are extraordinary symptoms [6].  Melloni et al. [3] have 
specified that lesions are 3 cm and under in 61% of the cases 
and that radiologically, lesions with pneumonic infiltrations in 
the lower lobes are seen in 28% of the cases. Yet, in a series 
of Cerfolio et al. [1], mean tumor diameter of the cases is 4 cm 
(between 1 and 15 cm) and lesions of 48% of the cases are 
masses. Since a high rate of the patients was symptomatic in 
the series of Cerfolio et al. [1], it makes us think that symptoms 
may be associated with not only the location of the lesion but 
also with its size. Radiologic findings show differences in 
invasive and noninvasive forms of the lesion, which also 
asserts mortality suspicion. Hirai et al. [7] have detected 
irregularly-marginated lesions in 36%, spicule contour lesions 
in 18% and lesions showing pleural notch in 18% of the 
patients, and emphasized that it is difficult to differentiate IMTs 
from primary pulmonary cancers. FDG-PET may be helpful in 
malignity differentiation; however, it should not be forgotten 
that its specifity is low in cases with acute, active inflammation 
[7]. Calcification is not generally seen in small lesions. Fabre 
et al. [2] have reported calcification in 6 of the 7 patients with 
lesions larger than 4 cm. The tumor was 6.5 cm in our case 
and showed intense calcification, and thus, FDG-PET was not 
performed. Pulmonary lesions that may cause calcification 
(like hamartoma, teratoma and Castleman disease) were 
considered in differential diagnosis. There is no specific 
distinguishing characteristic in cardiac lesions. 
Echocardiography is generally used in diagnosis [4,5]. While 
the ones located in the left atrium may lead to pulmonary 
edema, the ones located in the right atrium may cause vena 
cava inferior thrombosis, liver congestion or vena cava 
superior disease [4,5]. 
Bronchoscopy and transthoracic needle biopsy (TTNB) are 
mostly not helpful in diagnosis. In the series of Fabre et al. 
[2], diagnosis was made with bronchoscopy in 16% of the 
patients and with TTNB in 8% of the patients. Therefore, 
surgery is generally necessary in diagnosis and treatment [1]. 
Videothoracoscopic surgical resection with stable surgical 
margins is a good option in solitary pulmonary nodules [7]. 
Surgical excision is a diagnostic and treatment option in the 
ones with cardiac origin [5].
Some cases may progress locally invasive and invade the chest 
wall and mediastinal structures [1,2,7]. IMT, which is a rare 
tumor of mesenchymal origin, can be seen in nearly everywhere 
in the body [8]. Macroscopic findings of our case suggested 
that it may have been resulted from RIPV (Figure 3). No matter 
where it originates from, the main treatment of IMT is 
surgical excision [1-3,8]. The efficiency of nonsurgical 
treatments has not been established [3]. Local recurrence is 
very low in IMT of pulmonary origin; however, up to 25% 
recurrence can be seen in extrapulmonary IMT [4]. Survival 
is poor in both cardiac and pulmonary recurrences [1,3,4]. 
In conclusion, IMT is a rare neoplasm that may show 
radiologic resemblance to both benign and malignant lesions 
of the lungs with regard to localization, characteristics and 
size of the lesion. Despite being seen rarely and the low 
number of cases in series, the consensus is that a complete 
surgical resection is necessary for long-term survival. 
Written consent was obtained from the patient for all 
interventions performed. The consent also include the use of 
findings and images related to his disease for scientific and 
educational purposes.
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